623 related articles for article (PubMed ID: 21189404)
1. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
[TBL] [Abstract][Full Text] [Related]
2. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
Shi Y; Lo CS; Padda R; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Clin Sci (Lond); 2015 May; 128(10):649-63. PubMed ID: 25495544
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats.
Lo J; Patel VB; Wang Z; Levasseur J; Kaufman S; Penninger JM; Oudit GY
Exp Physiol; 2013 Jan; 98(1):109-22. PubMed ID: 22750422
[TBL] [Abstract][Full Text] [Related]
6. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY
Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.
Oudit GY; Kassiri Z; Patel MP; Chappell M; Butany J; Backx PH; Tsushima RG; Scholey JW; Khokha R; Penninger JM
Cardiovasc Res; 2007 Jul; 75(1):29-39. PubMed ID: 17499227
[TBL] [Abstract][Full Text] [Related]
8. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
[TBL] [Abstract][Full Text] [Related]
9. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome.
Bae EH; Fang F; Williams VR; Konvalinka A; Zhou X; Patel VB; Song X; John R; Oudit GY; Pei Y; Scholey JW
Kidney Int; 2017 Jun; 91(6):1347-1361. PubMed ID: 28249676
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.
Yang XH; Wang YH; Wang JJ; Liu YC; Deng W; Qin C; Gao JL; Zhang LY
Peptides; 2012 Jul; 36(1):60-70. PubMed ID: 22580272
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
13. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
Jin HY; Song B; Oudit GY; Davidge ST; Yu HM; Jiang YY; Gao PJ; Zhu DL; Ning G; Kassiri Z; Penninger JM; Zhong JC
PLoS One; 2012; 7(6):e38502. PubMed ID: 22693641
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
[TBL] [Abstract][Full Text] [Related]
15. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
16. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW
Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways.
Song B; Jin H; Yu X; Zhang Z; Yu H; Ye J; Xu Y; Zhou T; Oudit GY; Ye JY; Chen C; Gao P; Zhu D; Penninger JM; Zhong JC
Regul Pept; 2013 Aug; 185():44-51. PubMed ID: 23816468
[TBL] [Abstract][Full Text] [Related]
18. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation.
Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY
Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068
[TBL] [Abstract][Full Text] [Related]
19. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.
Chen LJ; Xu YL; Song B; Yu HM; Oudit GY; Xu R; Zhang ZZ; Jin HY; Chang Q; Zhu DL; Zhong JC
Peptides; 2016 May; 79():49-57. PubMed ID: 27018342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
